Database for high-risk nasopharyngeal carcinoma treated with chemoradiotherapy and immunotherapy

This dataset originates from a multicenter, open-label, randomized controlled trial investigating the efficacy of adding anti-PD-1 immunotherapy to concurrent chemoradiotherapy and adjuvant therapy following induction chemotherapy in patients with high-risk nasopharyngeal carcinoma (NPC). The primary research hypothesis is that the intensification of therapy with PD-1 inhibitors during and after concurrent chemoradiotherapy will significantly reduce the disease progression rate and improve overall survival outcomes for this high-risk patient population.
Data includes comprehensive baseline patient characteristics, treatment details, and follow-up data for survival and disease status endpoints.
This data set possesses significant reuse potential. Researchers can perform analyses to validate the primary findings, explore subgroup effects, or generate new hypotheses. Also, it can serve as a benchmark for developing or validating novel statistical methods or prognostic models for survi..., , # Database for high-risk nasopharyngeal carcinoma treated with chemoradiotherapy and immunotherapy

Dataset DOI: [10.5061/dryad.3j9kd51zg](https://doi.org/10.5061/dryad.3j9kd51zg)

## Description of the data and file structure

This dataset originates from a multicenter, open-label, randomized controlled trial investigating the efficacy of adding anti-PD-1 immunotherapy to concurrent chemoradiotherapy and adjuvant therapy following induction chemotherapy in patients with high-risk nasopharyngeal carcinoma.

### Files and variables

#### File: Database_for_High-Risk_Nasopharyngeal_Carcinoma_Treated_with_Chemoradiotherapy_and_Immunotherapy.xlsx

**Description:** The primary dataset is provided in a single Excel file. The variables are described below. Missing data in this dataset is indicated by \"NA\".

##### Variables

* No. : Patient ID
* center: The medical center where the patient received treatment, each number represents a hospital
* TNM stage: The TNM stage classification of the can...,